Join two expert faculty in this engaging evidence-based discussion focused on recent updates in the treatment of inflammatory bowel disease (IBD). View a custom whiteboard animation to gain a deeper understanding of the role of tumor necrosis factor (TNF) superfamily protein TNF-like 1A (TL1A) in this development of this disease. The latest clinical data for emerging agents that block this pathway will also be explored.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/new-avenues-treatment-inflammatory-bowel-disease
- Start Date: 2024-09-13 05:00:00
- End Date: 2024-09-13 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Merck (Any division) - Amount: 43166.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest